Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Revitalizing the General Practice Research Database: plans, challenges, and opportunities.

L Wood1, R Coulson

  • 1General Practice Research Database, Medicines Control Agency, Room 15-103 Market Towers, 1 Nine Elms Lane, Vauxhall, London SW8 5NQ, UK. louise.wood@gprd.com

Pharmacoepidemiology and Drug Safety
|January 23, 2002
PubMed
Summary

The General Practice Research Database (GPRD), a vital public health tool, faced viability issues. Management transferred to the UK Medicines Control Agency (MCA), which now outlines future plans for the GPRD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Searching smarter, not harder: leveraging AI to enhance literature searches for theory-driven reviews-A methodological case study.

BMC medical research methodology·2026
Same author

Withdrawal notice to: Impact of Provision of Abdominal Aortic Calcification Results on Cardiovascular Risk Reducing Behaviours: A 12-Week RCT [Heart, Lung and Circulation, Volume 33, Supplement 4, August 2024, Page S357].

Heart, lung & circulation·2024
Same author

WITHDRAWN: Impact of Provision of Abdominal Aortic Calcification Results on Cardiovascular Risk Reducing Behaviours: A 12-Week RCT.

Heart, lung & circulation·2024
Same author

Erratum to "The effects of the DASH dietary pattern on clinical outcomes and quality of life in adults with uncontrolled asthma: Design and methods of the ALOHA Trial" [Contemporary Clinical Trials 131 (2023) 107274].

Contemporary clinical trials·2024
Same author

The effects of the DASH dietary pattern on clinical outcomes and quality of life in adults with uncontrolled asthma: Design and methods of the ALOHA Trial.

Contemporary clinical trials·2023
Same author

A comparison of three identification kits for the confirmation of Aeromonas spp.

Letters in applied microbiology·2021

Area of Science:

  • Public Health Research
  • Health Informatics
  • Epidemiology

Background:

  • The General Practice Research Database (GPRD) is a significant global resource for anonymized, longitudinal patient records.
  • Recent challenges have jeopardized the GPRD's continued operation and utility.
  • The UK Medicines Control Agency (MCA) assumed management and financial control in April 1999.

Purpose of the Study:

  • To present the UK Medicines Control Agency's (MCA) strategic plans for the General Practice Research Database (GPRD).
  • To outline the future vision and operational direction for the GPRD under new management.
  • To address concerns regarding the GPRD's viability and ensure its continued role in public health research.

Main Methods:

  • Review of GPRD's historical management and operational context.

Related Experiment Videos

  • Analysis of the transfer of responsibility to the UK Medicines Control Agency (MCA).
  • Development of a strategic plan and future vision for the GPRD.

    • Main Results:

    • The presentation details the MCA's proposed management framework for the GPRD.
    • Future plans include enhancing data quality, accessibility, and research utility.
    • The MCA aims to secure the GPRD's long-term sustainability and public health impact.

    Conclusions:

    • The UK Medicines Control Agency (MCA) is committed to revitalizing the General Practice Research Database (GPRD).
    • Strategic management and future planning are crucial for maintaining the GPRD as a leading public health research tool.
    • The GPRD's continued operation under MCA stewardship is expected to support vital health research.